Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes

Recurrently mutated in lymphoid neoplasms, the transcription factor RFX7 is emerging as a tumor suppressor. Previous reports suggested that RFX7 may also have a role in neurological and metabolic disorders. We recently reported that RFX7 responds to p53 signaling and cellular stress. Furthermore, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, Katjana, Coronel, Luis, Riege, Konstantin, Sacramento, Erika K., Rahnis, Norman, Häckes, David, Cirri, Emilio, Groth, Marco, Hoffmann, Steve, Fischer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981735/
https://www.ncbi.nlm.nih.gov/pubmed/36864036
http://dx.doi.org/10.1038/s41420-023-01378-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981735/
https://www.ncbi.nlm.nih.gov/pubmed/36864036
http://dx.doi.org/10.1038/s41420-023-01378-1

Ejemplares similares